A study of histopathological features of medullary carcinoma of the thyroid: Cases from a single institute in India

Indian Journal of Cancer

Volumn 42, Issue 1, 2005, Pages 21-25

  Desai, Saral S ^a   Sarkar, Suchana ^a   Borges, Anita M ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Apoptosis; Clear; Medullary carcinoma; Papillary carcinoma; RET; Thyroid

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INDIA; MALE; MEDICAL RECORD; MEDULLARY CARCINOMA; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; CARCINOMA, MEDULLARY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INDIA; MALE; MEDICAL RECORDS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; THYROID NEOPLASMS;

EID: 22244489674     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-509x.15096     Document Type: Article

References (12)

1. Hazard JB, Hawk WA, Crile G Jr. Medullary (solid) carcinoma of the thyroid. A clinico-pathologic entity. J Clin Endocrinol Metab 1959;19:152-61.
2. Williams ED, Brown CL, Doniach I. Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid. J Clin Pathol 1966;19:103-13.
3. Wang DG, Liu WH, Johnston CF, Sloan JM, Buchanan KD. Bcl-2 and c-Myc, but not bax and p53, are expressed during human medullary thyroid tumorigenesis. Am J Pathol 1998;152:1407-13.
4. Wang W, Johansson H, Bergholm U, Wilander E, Grimelius L. Apoptosis and Expression of the Proto-Oncogenes bcl-2 and p53 and the Proliferation Factor Ki-67 in Human Medullary Thyroid Carcinoma. Endocr Pathol 1996;7:37-45.
5. Albores-Saavedra J, Gorraez de la Mora T, de la Torre-Rendon F, Gould E. Mixed medullary-papillary carcinoma of the thyroid. A previously unrecognized variant of thyroid carcinoma. Hum Pathol 1990;21:1151-5.
6. Matias-Guiu X, Caixas A, Costa I, Cabezas R, Prat J. Compound medullary-papillary carcinoma of the thyroid. True mixed tumor. Histopathology 1994;25:183-4.
7. Fusco A, Chiappetta G, Hui P, Garcia-Rostan G, Golden L, Kinder BK, et al. Assessment of RET/PTC Oncogene Activation and Clonality in Thyroid Nodules with Incomplete Morphological Evidence of Papillary Carcinoma. A Search for the Early Precursors of Papillary Cancer. Am J Pathol 2002;160:2157-67.
8. Sheils OM, O'Eary JJ, Uhlmann V, Lattich K, Sweeney EC. ret/PTC-1 Activation in Hashimoto Thyroiditis. Int J Surg Pathol 2000;8:185-9.
9. Inaba M, Umemura S, Satoh H, Abe Y, Kurokawa K, Sakai H, et al. Expression of RET in follicular cell-derived tumors of the thyroid gland: Prevalence and implication of morphological type. Pathol Int 2003;53:146-53.
10. Nikiforov YE. RET/PTC rearrangement in thyroid tumors. Endocr Pathol 2002;13:3-16.
11. Takahashi M. Oncogenic activation of the ret protooncogene in thyroid cancer. Crit Rev Oncog 1995;6:35-46.
12. Melillo RM, Cirafici AM, De Falco V, Bellantoni M, Chaippetta G, Fusco A, et al. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinomas. Am J Pathol 2004;165:511-21.